Search Results 161-170 of 4097 for ������������������������������������:VB20��������������������� ������
About this study. The purpose of this study is to measure the safety and effectiveness of the Maestro System to reduce body weight by blocking signals from ...
The purpose of this study is to administer a survey to elicit interest in participating in a future proposed trial involving a very slow tapering of opioid ...
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...
This will help determine the safety and feasibility of using cell-based regenerative therapy as an additional treatment for the management of HLHS.
Everolimus may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Brentuximab vedotin may interfere with the ability of ...
Monoclonal antibodies, such as nivolumab and brentuximab vedotin, may interfere with the ability of cancer cells to grow and spread. Participation eligibility.
The purpose of this study is to assess the effectiveness and safety of Lubiprostone in pediatric patients, aged ≥ 6 years to < 18 years, diagnosed with ...
About this study. The purpose of this research is to study immune cells called T cells and monocytes (types of blood cells that fight infection and can also ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.